Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

2.
3.

Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users.

Tucker T, Fry CL, Lintzeris N, Baldwin S, Ritter A, Donath S, Whelan G.

Addiction. 2004 Sep;99(9):1157-66.

PMID:
15317636
5.

Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.

Bird SM, Goldberg DJ, Hutchinson SJ.

J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.

PMID:
11437088
6.

The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users.

Hellard ME, Nguyen OK, Guy RJ, Jardine D, Mijch A, Higgs PG.

Aust N Z J Public Health. 2006 Dec;30(6):519-25.

PMID:
17209266
7.

Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.

Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M.

BMC Infect Dis. 2006 Jun 8;6:93.

8.

Sexual activity as a risk factor for hepatitis C in Puerto Rico.

De Jesús-Caraballo J, Toro DH, Rodríguez-Pérez F, Ruiz H, Dueño MI, Alvarez M, Suárez-Pérez E; Gastroenterology Association of Puerto Rico.

Bol Asoc Med P R. 2008 Jul-Sep;100(3):15-20.

PMID:
19227710
10.

HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention.

Hagan H, Thiede H, Des Jarlais DC.

AIDS. 2005 Oct;19 Suppl 3:S199-207. Review.

PMID:
16251818
11.

Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users.

Burt RD, Thiede H, Hagan H.

Drug Alcohol Depend. 2009 Dec 1;105(3):215-20. doi: 10.1016/j.drugalcdep.2009.07.005. Epub 2009 Aug 31.

PMID:
19720473
12.

Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.

Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.

AIDS. 1996 Mar;10(3):311-7.

PMID:
8882671
14.

The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.

Butler T, Boonwaat L, Hailstone S, Falconer T, Lems P, Ginley T, Read V, Smith N, Levy M, Dore G, Kaldor J.

Aust N Z J Public Health. 2007 Feb;31(1):44-50.

PMID:
17333608
15.

Description of a new hepatitis C risk assessment tool.

Nguyen MT, Herrine SK, Laine CA, Ruth K, Weinberg DS.

Arch Intern Med. 2005 Sep 26;165(17):2013-8.

PMID:
16186472
16.

Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Xia X, Luo J, Bai J, Yu R.

Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Review.

PMID:
18486955
17.

[The estimation of premorbid intelligence levels in French speakers].

Mackinnon A, Mulligan R.

Encephale. 2005 Jan-Feb;31(1 Pt 1):31-43. French.

PMID:
15971638
18.

Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program.

Giuliani M, Caprilli F, Gentili G, Maini A, Lepri AC, Prignano G, Palamara G, Giglio A, Crescimbeni E, Rezza G.

Sex Transm Dis. 1997 Oct;24(9):533-7.

PMID:
9339972
19.

Hitting up in the top end: characteristics of needle exchange clients in Darwin.

Roberts C, Crofts N.

Aust N Z J Public Health. 2000 Feb;24(1):82-5.

PMID:
10777985
20.

Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.

Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF.

J Clin Virol. 2009 Mar;44(3):200-6. doi: 10.1016/j.jcv.2008.12.008. Epub 2009 Feb 4.

PMID:
19195927
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk